1. Stocks
    2. /
  2. Moderna (NASDAQ: MRNA)
    3. /

Moderna (NASDAQ: MRNA) Share Price and News

$30.40 $-0.76 (-2.4%) 31 December 2025 at 7:58:58 am AEDT

Moderna Chart and Price Data

About Moderna

Last updated 31-12-2025, 07:58:58am AEDT
Current Price $30.40
Change $-0.76 (-2.4%)
Close Price $30.40
Open Price $31.14
Bid $30.31
Ask $30.47
Day Range $30.40 - $31.24
Year Range $22.28 - $48.92
Volume 178,806
Average Volume 10,663,558
Market Cap $12,171,364,100.00
Earnings Per Share $-8.06

    • Moderna (NASDAQ: MRNA)
    Latest News

    coronavirus vaccine represented by gloved hand drawing down from syringe
    International Stock News

    Johnson & Johnson coronavirus vaccine wins FDA authorisation

    | Eric Volkman

    The big pharmaceutical company's jab has some important advantages.

    Read more »

    A trader stand looking at a sharemarket graph emblazoned with the words buy and sell
    International Stock News

    Moderna stock: Buy the dip?

    | Taylor Carmichael

    The stock is down 9% after a valuation downgrade from Bank of America.

    Read more »

    covid vaccine stocks represented by doctor drawing vaccine from vial
    International Stock News

    Moderna says vaccine protects against all known variants

    | Jim Crumly

    A weaker response to the South African variant prompts studies of a strain-specific booster.

    Read more »

    covid vaccine shares represented by numbers 2021 with the one displayed as syringe
    Coronavirus News

    Pfizer COVID-19 vaccine given green light for use in Australia

    | Mitchell Lawler

    The TGA has approved the Pfizer COVID-19 vaccine for use in Australia. We take a look at some of the…

    Read more »

    Hand holding a pin next to a bubble with a dollar sign in it
    ⏸️ Risk Managment

    Will the ASX see a share market bubble in 2021?

    | Sebastian Bowen

    After a better-than-expected 2020, will the ASX share market see a bubble in 2021? This commentator thinks so, here's why

    Read more »

    covid vaccine stocks represented by little girl receiving vaccine needle
    International Stock News

    Moderna coronavirus vaccine approved in Europe

    | Eric Volkman

    The vaccine can now be distributed and administered throughout the 27-country European Union.

    Read more »

    covid vaccine stocks represented by row of vials labelled covid vaccine
    International Stock News

    How MRNA stock performed in 2020

    | Jason Hawthorne

    Shareholders were rewarded for holding through volatility.

    Read more »

    asx share price growth represented by hand holding hourglass surrounded by dollar signs
    International Stock News

    The worst mistake Moderna investors can make right now

    | Jason Hawthorne

    The COVID-19 vaccine could be the first of a long list of successes.

    Read more »

    A glass jar labelled COVID_19 vaccine sits on a bench with capsules and precriptions drugs.
    International Stock News

    Why Moderna stock fell 32% in December

    | Beth McKenna

    Investors in the COVID-19 vaccine maker took some profits last month.

    Read more »

    Hand with blue medical gloves holds vials of coronavirus vaccines
    International Stock News

    Moderna's stock has surged 488% in 2020: Is it a buy for 2021?

    | Sushree Mohanty

    This smaller biotech company attracted a lot of attention in 2020, but is it still worth an investment?

    Read more »

    asx share price boosted by us investment represented by hand waving US flag across winning athlete
    Share Market News

    Here are the US shares ASX investors are buying

    | Sebastian Bowen

    AirBnB Inc (NASDAQ: ABNB) and Tesla Inc (NASDAQ: TSLA) were amongst the US shares that ASX investors were buying last…

    Read more »

    shares of the future represented by investor drawing forward arrow on blackboard against backward facing arrows
    Investing Strategies

    How the 21st century actually started in 2020

    | Tony Yoo

    The new economy is here. So you better put your money on shares that will thrive this century, not the…

    Read more »

    Profile

    since

    Note